Skip to content

Nasdaq · CIK 0001040896

IDN Intellicheck, Inc.

Insider trading from SEC Form 4. Last filing Jun 16, 2026. Close $2.28 on Oct 9, 2026, +1% from the 52-week low and -75% from the high.

Intellicheck, Inc. (IDN) has 48 SEC Form 4 filings on file from 8 insiders, the latest filed on Jun 16, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

9 open-market trades have been scored at IDN. The newest: Jonathan Robins (Chief Technology Officer) sold $23k of stock on Jun 15, 2026, filed Jun 16, 2026, scored 35 (weak). The largest of the 9 shown: Gregory Braca (director) sold $188k on May 22, 2025, scored 47 (moderate).

IDN closed at $2.28 on Oct 9, 2026, 1% above its 52-week low and 75% below its 52-week high.

4 Form 144 notices of planned sales are on file, the latest filed Sep 10, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company

Price and insider trades, last year

IDNOct 9, 2026 · close 2.28

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Intellicheck, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
35WeakJonathan Robins
Chief Technology Officer
sell
$23k
5,550 shares
-100%+2% from low-54% from high
19WeakBryan Lewis
CEO/President
sell
$81k
10,000 shares
-20%+213% from low-12% from high
19WeakBryan Lewis
CEO/President
sell
$85k
10,000 shares
-17%+272% from low0% from high
19WeakBryan Lewis
CEO/President
sell
$80k
10,000 shares
-14%+257% from low0% from high
18WeakBryan Lewis
CEO/President
sell
$75k
10,000 shares
-13%+240% from low-1% from high
10WeakGuy L Smith
director
buy
$6,180
1,000 shares
+0%-
47ModerateGregory Braca
director
sell
$188k
48,297 shares
-85%-
41ModerateGregory Braca
director
sell
$33k
7,703 shares
-90%-
10WeakGuy L Smith
director
buy
$9,327
2,500 shares
+1%-

Planned sales

Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales

FiledSellerSharesValueSale datePast 3 months
Sep 10, 2025 AdamSragovicz
Affiliate
18,628
0.09% of outstanding
$101kSep 10, 2025none
Jun 10, 2025 Bryan Lewis
Affiliate
41,144
0.21% of outstanding
$246kJun 10, 2025none
May 22, 2025 Gregory B. Braca
Director
56,000
0.28% of outstanding
$237kMay 22, 2025none
Dec 10, 2024 Gregory B. Braca
Director
52,500
0.27% of outstanding
$159kDec 10, 2024none

Transactions

The newest 50 of 136 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 15, 2026Jonathan Robins
Chief Technology Officer
SOpen-market sale
Common Stock, $.001 par value
-5,550$4.22$23k0Jun 16, 2026
May 1, 2026Bryan Lewis
CEO/President
GGift
Common Stock, $.001 par valueindirect: The Lewis Family Revocable Living Trust
-6,270$0.00$033,730May 7, 2026
Apr 27, 2026Bryan Lewis
CEO/President
SOpen-market sale
Common Stock, $.001 par valueindirect: The Lewis Family Revocable Living Trust10b5-1
-10,000$8.05$81k40,000Apr 28, 2026
Apr 20, 2026Bryan Lewis
CEO/President
SOpen-market sale
Common Stock, $.001 par valueindirect: The Lewis Family Revocable Living Trust10b5-1
-10,000$8.51$85k50,000Apr 21, 2026
Apr 13, 2026Bryan Lewis
CEO/President
SOpen-market sale
Common Stock, $.001 par valueindirect: The Lewis Family Revocable Living Trust10b5-1
-10,000$7.95$80k60,000Apr 14, 2026
Apr 6, 2026Bryan Lewis
CEO/President
GGift
Common Stock, $.001 par value10b5-1
-80,000$0.00$0327,126Apr 7, 2026
Apr 6, 2026Bryan Lewis
CEO/President
SOpen-market sale
Common Stock, $.001 par valueindirect: The Lewis Family Revocable Living Trust10b5-1
-10,000$7.53$75k70,000Apr 7, 2026
Mar 31, 2026Dondi Black
director
AGrant or award
Common Stock, $.001 par value
+715$6.99$4,99823,476Apr 6, 2026
Mar 31, 2026Gregory Braca
director
AGrant or award
Common Stock, $.001 par value
+3,577$6.99$25k8,325Apr 6, 2026
Mar 31, 2026Dylan Glenn
director
AGrant or award
Common Stock, $.001 par value
+3,577$6.99$25k88,764Apr 6, 2026
Mar 31, 2026Guy L Smith
director
AGrant or award
Common Stock, $.001 par value
+4,292$6.99$30k423,602Apr 6, 2026
Mar 24, 2026Adam Sragovicz
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+100,351$0.00$0100,351Mar 26, 2026
Mar 24, 2026Bryan Lewis
CEO/President
AGrant or award
Stock Option (Right to Buy)derivative
+146,300$0.00$0146,300Mar 26, 2026
Mar 24, 2026Jonathan Robins
Chief Technology Officer
AGrant or award
Stock Option (Right to Buy)derivative
+77,000$0.00$077,000Mar 26, 2026
Jan 5, 2026Gregory Braca
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+3,925$0.00$03,925Jan 7, 2026
Jan 5, 2026Dylan Glenn
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+2,355$0.00$02,355Jan 7, 2026
Jan 5, 2026David E Ullman
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+1,962$0.00$01,962Jan 7, 2026
Jan 5, 2026Guy L Smith
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+4,710$0.00$04,710Jan 7, 2026
Jan 5, 2026Dondi Black
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+785$0.00$0785Jan 7, 2026
Nov 25, 2025Guy L Smith
director
POpen-market purchase
Common Stock, $.001 par value
+1,000$6.18$6,180392,948Nov 25, 2025
Sep 30, 2025Dondi Black
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+962$0.00$0962Oct 10, 2025
Sep 30, 2025Dondi Black
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+2,404$0.00$02,404Oct 2, 2025
Sep 30, 2025Dylan Glenn
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+2,404$0.00$02,404Oct 2, 2025
Sep 30, 2025Guy L Smith
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+5,769$0.00$05,769Oct 2, 2025
Sep 10, 2025Adam Sragovicz
Chief Financial Officer
MOption exercise
Common Stock, $.001 par value
+45,429$2.21$100k55,429Sep 11, 2025
Sep 10, 2025Adam Sragovicz
Chief Financial Officer
FTax withholding
Common Stock, $.001 par value
-18,628$5.41$101k36,801Sep 11, 2025
Sep 10, 2025Adam Sragovicz
Chief Financial Officer
MOption exercise
Stock Option (Right to Buy)derivative
+45,249$0.00$045,249Sep 11, 2025
Jul 14, 2025Dondi Black
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+952$0.00$0952Jul 15, 2025
Jul 14, 2025Dylan Glenn
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+2,381$0.00$02,381Jul 15, 2025
Jul 14, 2025Guy L Smith
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+5,714$0.00$05,714Jul 15, 2025
Jul 14, 2025David E Ullman
director
AGrant or award
Restricted Stock Units (RSU's)derivative
+2,381$0.00$02,381Jul 15, 2025
Jun 10, 2025Bryan Lewis
CEO/President
MOption exercise
Common Stock, $.001 par value
+20,809$2.02$42k373,411Jun 11, 2025
Jun 10, 2025Bryan Lewis
CEO/President
MOption exercise
Common Stock, $.001 par value
+15,607$2.53$39k389,018Jun 11, 2025
Jun 10, 2025Bryan Lewis
CEO/President
MOption exercise
Common Stock, $.001 par value
+9,378$3.03$28k398,396Jun 11, 2025
Jun 10, 2025Bryan Lewis
CEO/President
MOption exercise
Common Stock, $.001 par value
+49,875$2.70$135k448,271Jun 11, 2025
Jun 10, 2025Bryan Lewis
CEO/President
FTax withholding
Common Stock, $.001 par value
-41,145$5.97$246k407,126Jun 11, 2025
Jun 10, 2025Bryan Lewis
CEO/President
MOption exercise
Stock Option (Right to Buy)derivative
-20,809$0.00$024,591Jun 11, 2025
Jun 10, 2025Bryan Lewis
CEO/President
MOption exercise
Stock Option (Right to Buy)derivative
-15,607$0.00$018,443Jun 11, 2025
Jun 10, 2025Bryan Lewis
CEO/President
MOption exercise
Stock Option (Right to Buy)derivative
-9,378$0.00$024,672Jun 11, 2025
Jun 10, 2025Bryan Lewis
CEO/President
MOption exercise
Stock Option (Right to Buy)derivative
-49,875$0.00$016,625Jun 11, 2025
May 23, 2025Guy L Smith
director
POpen-market purchase
Common Stock, $.001 par value
+2,500$3.73$9,327391,948May 23, 2025
May 22, 2025Gregory Braca
director
SOpen-market sale
Common Stock, $.001 par value
-200$3.78$75556,623May 23, 2025
May 22, 2025Gregory Braca
director
SOpen-market sale
Common Stock, $.001 par value
-746$4.18$3,1187,780May 23, 2025
May 22, 2025Gregory Braca
director
SOpen-market sale
Common Stock, $.001 par value
-4,641$3.79$18k51,982May 23, 2025
May 22, 2025Gregory Braca
director
SOpen-market sale
Common Stock, $.001 par value
-34$4.19$1427,746May 23, 2025
May 22, 2025Gregory Braca
director
SOpen-market sale
Common Stock, $.001 par value
-100$3.80$38051,882May 23, 2025
May 22, 2025Gregory Braca
director
SOpen-market sale
Common Stock, $.001 par value
-21$4.19$887,725May 23, 2025
May 22, 2025Gregory Braca
director
SOpen-market sale
Common Stock, $.001 par value
-7,736$3.80$29k44,146May 23, 2025
May 22, 2025Gregory Braca
director
SOpen-market sale
Common Stock, $.001 par value
-6$4.20$257,719May 23, 2025
May 22, 2025Gregory Braca
director
SOpen-market sale
Common Stock, $.001 par value
-200$3.81$76143,946May 23, 2025
50 of 136 rows shown.

Insiders

Everyone who has filed a Form 4 here.

Questions about IDN

Answered from the filings on this page, as of the latest one.

Are insiders buying IDN?

No. In the last 90 days no insider at Intellicheck, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade IDN on the open market?

Jonathan Robins (Chief Technology Officer) sold $23k of IDN on Jun 15, 2026 and filed the Form 4 on Jun 16, 2026. InsiderTell scored 35 (weak).

How many insiders file Form 4 at Intellicheck, Inc.?

8 people have filed a Form 4 at Intellicheck, Inc., among them Dondi Black (director), Gregory Braca (director), Dylan Glenn (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.